Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 15
Submit an article Journal homepage
2,166
Views
73
CrossRef citations to date
0
Altmetric
Review

Innovative therapies for neovascular age-related macular degeneration

Hasenin Al-KhersanDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USAView further author information
,
Rehan M. HussainDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence[email protected]
View further author information
,
Thomas A. CiullaDepartment of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA;Retina Service, Midwest Eye Institute, Indianapolis, IN, USA;Clearside Biomedical, Alpharetta, GA, USAView further author information
&
Pravin U. DugelRetinal Consultants of Arizona, Phoenix, Arizona;USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USAView further author information
Pages 1879-1891 | Received 07 Mar 2019, Accepted 21 Jun 2019, Published online: 12 Jul 2019

Citations (73)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Colin S Tan, Wei Kiong Ngo, Isaac W Chay, Dominic S Ting & SriniVas R Sadda. (2022) Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options. Clinical Ophthalmology 16, pages 917-933.
Read now
Zhiqing Chen, Kailin Chen, Jinyu Li$suffix/text()$suffix/text(), Junhui Shen & Wen Xu. (2022) Elevated Levels of Endoglin, Endostatin, FGF-α, HGF, and Thrombospondin-2 in Aqueous Humor of nAMD Patients. Ocular Immunology and Inflammation 30:5, pages 1092-1098.
Read now
Kayla M. Rudeen, Wenqiang Liu, William F. Mieler & Jennifer J. Kang-Mieler. (2022) Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System. Current Eye Research 47:7, pages 1034-1042.
Read now
Amber T. Wolf, Alon Harris, Francesco Oddone, Brent Siesky, Alice Verticchio Vercellin & Thomas A. Ciulla. (2022) Disease progression pathways of wet AMD: opportunities for new target discovery. Expert Opinion on Therapeutic Targets 26:1, pages 5-12.
Read now
Stephanie M Kaiser, Sruthi Arepalli & Justis P Ehlers. (2021) Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration. Journal of Experimental Pharmacology 13, pages 905-912.
Read now
Rehan M Hussain, Bilal A Shaukat, Lauren M Ciulla, Audina M Berrocal & Jayanth Sridhar. (2021) Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration. Drug Design, Development and Therapy 15, pages 2653-2665.
Read now
Anat Loewenstein & Tiarnan D. L. Keenan. (2021) Perspectives on remote patient monitoring with self-operated OCT for management of neovascular age-related macular degeneration. Expert Review of Ophthalmology 16:6, pages 425-429.
Read now
Masumi G. Asahi, Jaycob Avaylon, Josh Wallsh & Ron P. Gallemore. (2021) Emerging biological therapies for the treatment of age-related macular degeneration. Expert Opinion on Emerging Drugs 26:2, pages 193-207.
Read now
Massimo Nicolò, Lorenzo Ferro Desideri, Aldo Vagge & Carlo Enrico Traverso. (2021) Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases. Expert Opinion on Investigational Drugs 30:3, pages 193-200.
Read now
Jean-François Korobelnik, Cécile Delcourt, Catherine Creuzot-Garcher, Asma Melaine, Jules Chassetuillier, Anne Lejeune, Stève Bénard & Laure Dupont-Benjamin. (2021) Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data. Journal of Medical Economics 24:1, pages 1087-1097.
Read now
Ee Lin Ong, Kimberly Spooner, Thomas Hong & Andrew Chang. (2020) Brolucizumab: an evolution in treatment for neovascular age-related macular degeneration. Expert Review of Ophthalmology 15:2, pages 71-81.
Read now
Rehan M. Hussain, Ashley E. Neiweem, Viral Kansara, Alon Harris & Thomas A. Ciulla. (2019) Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease. Expert Opinion on Investigational Drugs 28:10, pages 861-869.
Read now
Claudiu T. Supuran. (2019) Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review. Expert Opinion on Therapeutic Patents 29:10, pages 761-767.
Read now

Articles from other publishers (60)

Weiye Li & Jingfa Zhang. 2024. Therapeutic Targets for Diabetic Retinopathy. Therapeutic Targets for Diabetic Retinopathy 215 263 .
Xinyi Jiao, Xingru Peng, Xin Jin, Ning Liu, Yang Yu, Rui Liu & Zheng Li. (2023) Nano-composite system of traditional Chinese medicine for ocular applications: molecular docking and three-dimensional modeling insight for intelligent drug evaluation. Drug Delivery and Translational Research 13:12, pages 3132-3144.
Crossref
Vivek P. Chavda, Pankti C. Balar, Srushti B. Patel, Diya J. Bhavsar, Margi V. Lakhani & Resa Parmar. (2023) Antibody biopolymer conjugate. Physical Sciences Reviews 0:0.
Crossref
Tiarnan D.L. Keenan & Anat Loewenstein. (2023) Artificial intelligence for home monitoring devices. Current Opinion in Ophthalmology 34:5, pages 441-448.
Crossref
Neetu Kushwah, Kiran Bora, Meenakshi Maurya, Madeline C. Pavlovich & Jing Chen. (2023) Oxidative Stress and Antioxidants in Age-Related Macular Degeneration. Antioxidants 12:7, pages 1379.
Crossref
Michelle Koerselman, Lisanne C.M. Morshuis & Marcel Karperien. (2023) The use of peptides, aptamers, and variable domains of heavy chain only antibodies in tissue engineering and regenerative medicine. Acta Biomaterialia.
Crossref
Madhurima Chaudhuri, Yusra Hassan, Pansy Prardhana Sinha Bakka Vemana, Muktha S Bellary Pattanashetty, Zain U Abdin & Humza F Siddiqui. (2023) Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness. Cureus.
Crossref
Weiming Ren, Suyang Duan, Chao Dai, Chunbao Xie, Lingxi Jiang & Yi Shi. (2023) Nanotechnology Lighting the Way for Gene Therapy in Ophthalmopathy: From Opportunities toward Applications. Molecules 28:8, pages 3500.
Crossref
John Hovanesian, I Paul Singh, Aditi Bauskar, Srilatha Vantipalli, Rabia Gurses Ozden & Michael H. Goldstein. (2023) Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy. Current Opinion in Ophthalmology 34:Supplement 1, pages S1-S13.
Crossref
Christelle Monville, Olivier Goureau & Karim Ben M'Barek. (2023) Photoreceptor Cell Replacement Using Pluripotent Stem Cells: Current Knowledge and Remaining Questions. Cold Spring Harbor Perspectives in Medicine 13:2, pages a041309.
Crossref
Peter K. Kaiser, Andrea Giani, Holger Fuchs, Victor Chong & Jeffery S. Heier. (2023) Factors That Can Prolong Ocular Treatment Duration in Age-Related Macular Degeneration. Ophthalmic Research, pages 653-663.
Crossref
Jesus H. Gonzalez-Cortes, Victor A. Martinez-Pacheco, Jesus E. Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Jesus Mohamed-Hamsho, Laurent Kodjikian & Thibaud Mathis. (2022) Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema. Pharmaceutics 15:1, pages 122.
Crossref
Ziyan Xie & Xinhua Xiao. (2022) Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives. Frontiers in Endocrinology 13.
Crossref
Jingfa Zhang, Jingxiang Zhang, Chaoyang Zhang, Jingting Zhang, Limin Gu, Dawei Luo & Qinghua Qiu. (2022) Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications. Cells 11:21, pages 3362.
Crossref
Samaneh ToutounchianNaser AhmadbeigiVahid Mansouri. (2022) Retinal and Choroidal Neovascularization Antivascular Endothelial Growth Factor Treatments: The Role of Gene Therapy. Journal of Ocular Pharmacology and Therapeutics 38:8, pages 529-548.
Crossref
Aira Sarkar, Srushti Jayesh Sodha, Vijayabhaskarreddy Junnuthula, Praveen Kolimi & Sathish Dyawanapelly. (2022) Novel and investigational therapies for wet and dry age-related macular degeneration. Drug Discovery Today 27:8, pages 2322-2332.
Crossref
Faruque Ghanchi, Rupert Bourne, Susan M. Downes, Richard Gale, Christina Rennie, Ian Tapply & Sobha Sivaprasad. (2022) An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma. Eye 36:6, pages 1154-1167.
Crossref
Shirin Tavakoli, Jooseppi Puranen, Sina Bahrpeyma, Veera E. Lautala, Suvi Karumo, Tatu Lajunen, Eva M. del Amo, Marika Ruponen & Arto Urtti. (2022) Liposomal sunitinib for ocular drug delivery: A potential treatment for choroidal neovascularization. International Journal of Pharmaceutics 620, pages 121725.
Crossref
N. A. Gavrilova, N. S. Gadzhieva, O. E. Tishchenko & A. V. Zinov’eva. (2022) Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review. Ophthalmology in Russia 19:1, pages 22-32.
Crossref
Ana Rita Fernandes, Aleksandra Zielińska, Elena Sanchez-Lopez, Tiago dos Santos, Maria Luisa Garcia, Amelia M. Silva, Jacek Karczewski & Eliana B. Souto. (2022) Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options. International Journal of Molecular Sciences 23:5, pages 2592.
Crossref
Małgorzata Mrowicka, Jerzy Mrowicki, Ewa Kucharska & Ireneusz Majsterek. (2022) Lutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration—Neurodegenerative Disease. Nutrients 14:4, pages 827.
Crossref
Chuqi Wang & Ming Chu. (2022) Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis. Frontiers in Oncology 11.
Crossref
O.V. Zaytseva, N.V. Neroeva, T.D. Okhotsimskaya & E.V. Bobykin. (2022) Current view on the issue of insufficient effectiveness of anti-VEGF therapy for age-related macular degeneration. Vestnik oftal'mologii 138:1, pages 90.
Crossref
Juan Manuel Martinez-Alejo, Leopoldo Martin Baiza-Duran & Juan de Dios Quintana-Hau. (2022) Novel therapies for proliferative retinopathies. Therapeutic Advances in Chronic Disease 13, pages 204062232211403.
Crossref
Alexander Foss, Tryfon Rotsos, Theo Empeslidis & Victor Chong. (2022) Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment. Ophthalmologica 245:3, pages 204-217.
Crossref
Noam D. Rudnick, Leo A. Kim & Jason Comander. (2022) Adeno-associated Viral Vectors in the Retina: Delivering Gene Therapy to the Right Destination. International Ophthalmology Clinics 62:2, pages 215-229.
Crossref
Niamh MahonKayleigh SlaterJustine O'BrienYolanda AlvarezAlison ReynoldsBreandán Kennedy. (2022) Discovery and Development of the Quininib Series of Ocular Drugs. Journal of Ocular Pharmacology and Therapeutics 38:1, pages 33-42.
Crossref
Da Lv, Donglong Chen, Zhijie Wang, Zekai Cui, Jacey Hongjie Ma, Shangli Ji, Jiansu Chen & Shibo Tang. (2022) COL10A1 is a novel factor in the development of choroidal neovascularization. Microvascular Research 139, pages 104239.
Crossref
Monville Christelle, Morizur Lise & Karim Ben M'Barek. 2022. Current Challenges in Cell Therapy for Neurodegenerative Diseases. Current Challenges in Cell Therapy for Neurodegenerative Diseases 49 77 .
Weiye Li. 2022. Age-Related Macular Degeneration. Age-Related Macular Degeneration 261 272 .
Weiye Li. 2022. Age-Related Macular Degeneration. Age-Related Macular Degeneration 233 260 .
Dionysis D. Balatsoukas, Konstantinos T. Tsaousis, Konstadinos G. Boboridis, Anastasios G. Konstas & Fotis Topouzis. (2021) Emerging Treatment Modalities for Neovascular Age-Related Macular Degeneration: A Systematic Overview. Advances in Therapy 39:1, pages 5-32.
Crossref
M. V. Budzinskaya & A. A. Plyukhova. (2021) Future Perspectives for Antiangiogenic Therapy in Retinal Diseases. Ophthalmology in Russia 18:3S, pages 638-645.
Crossref
Sruthi Arepalli & Peter K. Kaiser. (2021) Pipeline therapies for neovascular age related macular degeneration. International Journal of Retina and Vitreous 7:1.
Crossref
Daniela Ferrara, Elizabeth M. Newton & Aaron Y. Lee. (2021) Artificial intelligence-based predictions in neovascular age-related macular degeneration. Current Opinion in Ophthalmology 32:5, pages 389-396.
Crossref
Maja Szymanska, Daanyaal Mahmood, Timothy E. Yap & Maria F. Cordeiro. (2021) Recent Advancements in the Medical Treatment of Diabetic Retinal Disease. International Journal of Molecular Sciences 22:17, pages 9441.
Crossref
Tiarnan D.L. Keenan, Michaella Goldstein, Dafna Goldenberg, Dinah Zur, Shiri Shulman & Anat Loewenstein. (2021) Prospective, Longitudinal Pilot Study. Ophthalmology Science 1:2, pages 100034.
Crossref
Sophie Négrel & Jean Michel Brunel. (2021) Synthesis and Biological Activities of Naturally Functionalized Polyamines: An Overview. Current Medicinal Chemistry 28:17, pages 3406-3448.
Crossref
Priyatham S. Mettu, Michael J. Allingham & Scott W. Cousins. (2021) Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities. Progress in Retinal and Eye Research 82, pages 100906.
Crossref
Justus G. Garweg & Christin Gerhardt. (2021) Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis. Graefe's Archive for Clinical and Experimental Ophthalmology.
Crossref
Majda Hadziahmetovic & Goldis Malek. (2021) Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies. Frontiers in Cell and Developmental Biology 8.
Crossref
Aamir A Aziz, Majid Khan, Caroline R Baumal & Arshad M Khanani. (2021) Faricimab: An Emerging Therapy for the Treatment of Neovascular Age-related Macular Degeneration. Ophthalmology 15:1, pages 23.
Crossref
Rehan M. Hussain, Andrea Neal, Nicolas A. Yannuzzi, Kevin H. Patel, Siya Huo, Seenu M. Hariprasad & Sumit P. Bhatia. (2021) Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments. Therapeutic Advances in Ophthalmology 13, pages 251584142110559.
Crossref
Priya R. Chandrasekaran & V.G. Madanagopalan. (2021) KSI-301: antibody biopolymer conjugate in retinal disorders. Therapeutic Advances in Ophthalmology 13, pages 251584142110277.
Crossref
Aira Sarkar & Sathish Dyawanapelly. (2021) Nanodiagnostics and Nanotherapeutics for age-related macular degeneration. Journal of Controlled Release 329, pages 1262-1282.
Crossref
Alexandria E. Linton, Erica M. Weekman & Donna M. Wilcock. (2021) Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention. Cerebral Circulation - Cognition and Behavior 2, pages 100030.
Crossref
Mohammad Ali Sadiq, Muhammad Sohail Halim, Muhammad Hassan, Neil Onghanseng, Irmak Karaca, Aniruddha Agarwal, Rubbia Afridi, Yasir J. Sepah, Diana V. Do & Quan Dong Nguyen. (2020) RETRACTED ARTICLE: Pharmacological agents in development for diabetic macular edema. International Journal of Retina and Vitreous 6:1.
Crossref
Anthony P. Adamis, Christopher J. Brittain, Atul Dandekar & J. Jill Hopkins. (2020) Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade. Eye 34:11, pages 1966-1972.
Crossref
Fan-Li Lin, Peng-Yuan Wang, Yu-Fan Chuang, Jiang-Hui Wang, Vickie H.Y. Wong, Bang V. Bui & Guei-Sheung Liu. (2020) Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update. Molecular Therapy 28:10, pages 2120-2138.
Crossref
Claudio Campa. (2020) New Anti-VEGF Drugs in Ophthalmology. Current Drug Targets 21:12, pages 1194-1200.
Crossref
Lise Morizur, Elise Herardot, Christelle Monville & Karim Ben M'Barek. (2020) Human pluripotent stem cells: A toolbox to understand and treat retinal degeneration. Molecular and Cellular Neuroscience 107, pages 103523.
Crossref
Majid Khan, Aamir A. Aziz, Noah A. Shafi, Tayeb Abbas & Arshad M. Khanani. (2020) Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab. Cells 9:8, pages 1869.
Crossref
Xinru Zhang, Shuhan Li, Yue Tang, Yuzun Guo & Shuai Gao. (2020) Intractable Ocular Diseases and Treatment Progress. AAPS PharmSciTech 21:6.
Crossref
Marib Akanda, Alexander Weiss & Ronni Lieberman. (2020) Update and Advances in Long-Acting Anti–Vascular Endothelial Growth Factor Agents. Advances in Ophthalmology and Optometry 5, pages 141-146.
Crossref
Sahar Awwad, Christin Henein, Nkiruka Ibeanu, Peng T. Khaw & Steve Brocchini. (2020) Preclinical challenges for developing long acting intravitreal medicines. European Journal of Pharmaceutics and Biopharmaceutics 153, pages 130-149.
Crossref
Jing Wang, Peng-Fei Jiang, Min Liu, Ming-Rong Kou, Jia-Ying Lei, Xiao-Ting Yu, Ying Zhao, Hong Wang & Lin-Na Zhang. (2020) Efficacy of intravitreal injection of conbercept on non-proliferative diabetic retinopathy: a retrospective study. Journal of International Medical Research 48:4, pages 030006051989317.
Crossref
Bingyu Zhang, Xue Yin, Jianqing Li, Chi Ren, Weiming Liu, Gaoqin Liu & Peirong Lu. (2020) Essential contribution of macrophage Tie2 signal mediated autophagy in laser-induced choroidal neovascularization. Experimental Eye Research 193, pages 107972.
Crossref
Georgios D Panos. (2020) Advances in intravitreal therapy and implants: where are we now?. Therapeutic Delivery 11:2, pages 69-73.
Crossref
P.V. Muñoz-Ramón, P. Hernández Martínez & F.J. Muñoz-Negrete. (2020) Nuevas dianas terapéuticas en el tratamiento de la degeneración macular asociada a la edad. Archivos de la Sociedad Española de Oftalmología 95:2, pages 75-83.
Crossref
Konstantin Petrukhin. 2020. Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases. Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases 125 160 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.